IDARUCIZUMAB (Praxbind)
Clinical Indication
Reversal of severe bleeding due to dabigatran
Date of classification
April 2016
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.